IP Library Granted Patent US 8,062,886
Granted Patent B2
US 8,062,886 · App. 11/986,041 · Granted Nov 22, 2011

Plasmid system for multigene expression

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,062,886
App. No.
11/986,041
Granted
Nov 22, 2011
Kind
B2
Abstract

The present invention provides a plasmid system which facilitates the construction of a single amplifiable plasmid that, having the potential to accommodate many independent expression cassettes, has the ability to express multi-subunit complex proteins such as antibodies and receptors.

Claims (13)

1. A method for producing an antibody comprising culturing an isolated host cell comprising a recombined amplifiable vector under conditions favorable to expression of cassettes in said vector; which vector is the product of a method comprising:

(a) introducing one or more expression cassettes encoding an immunoglobulin light chain or immunoglobulin heavy chain of said antibody into the multiple cloning site of a first universal transfer vector comprising a first multiple cloning site which comprises nucleotides 620-766 of the nucleotide sequence set forth in SEQ ID NO: 2; wherein said multiple cloning site is in said orientation or in a reverse orientation;

(b) introducing one or more expression cassettes encoding an immunoglobulin light chain or heavy chain of said antibody, different from the cassettes introduced into said first universal transfer vector, into a second universal transfer vector comprising a second multiple cloning site which comprises nucleotides 620-772 of the nucleotide sequence set forth in SEQ ID NO: 1; wherein said multiple cloning site is in said orientation or in a reverse orientation; and

(c) introducing said cassettes from steps (a) and (b) into an amplifiable vector comprising a third multiple cloning site, comprising nucleotides 5037-5183 of the nucleotide sequence set forth in SEQ ID NO: 3; wherein said multiple cloning site is in said orientation or in a reverse orientation; and wherein the cassettes from steps (a) and (b) encode an immunoglobulin light chain and an immunoglobulin heavy chain, of said antibody.

2. The method of claim 1 wherein said first or second cassette comprises a polynucleotide encoding a polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 20 and the other cassette comprises a polynucleotide encoding a polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 22.

3. The method of claim 2 wherein said polynucleotide encoding said polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 20 comprises the nucleotide sequence set forth in SEQ ID NO: 19 and wherein said polynucleotide encoding said polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 22 comprises the nucleotide sequence set forth in SEQ ID NO: 21.

4. The method of claim 1 wherein said first universal transfer vector comprises the plasmid map set forth in FIG. 2 .

5. The method of claim 1 wherein said second universal transfer vector comprises the plasmid map set forth in FIG. 1 .

6. The method of claim 1 wherein said amplifiable vector comprises the plasmid map set forth in FIG. 3 .

7. The method of claim 1 wherein said first universal transfer vector comprises the nucleotide sequence set forth in SEQ ID NO: 2.

8. The method of claim 1 wherein said second universal transfer vector comprises the nucleotide sequence set forth in SEQ ID NO: 1.

9. The method of claim 1 wherein said amplifiable vector comprises the nucleotide sequence set forth in SEQ ID NO: 3.

10. The method of claim 1 wherein one set of expression cassettes comprises a polynucleotide, operably associated with a promoter, which polynucleotide encodes an anti-IGFR1 antibody immunoglobulin heavy chain and the other set of expression cassettes comprises a polynucleotide, operably associated with a promoter, which polynucleotide encodes an anti-IGFR1 antibody immunoglobulin light chain.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →